Pfizer (PFE)
$28.05
0.35 (1.26%)
PFE Stock Quote Delayed 30 Minutes
5 Top Stock Trades for Tuesday: FB, NFLX, GILD, TSLA
Gilead Sciences, Pfizer, Tesla, Netflx and Facebook are our top stock trades for Tuesday. Here's a look at the charts.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
157.27B
PE Ratio
-561.00
EPS
-0.05
Volume (Avg. Vol.)
17.27M
Day's Range
$27.67 - $28.09
52-Week Range
$25.20 - $37.80
Dividend & Yield
$1.64 (5.85%)
PFE Stock Predictions, Articles, and Pfizer News
Credit Suisse Absolutely Is Right to Double Down on Pfizer Stock
Buy Pfizer stock on this current round of weakness. The underpinnings are bullish for 2020 and beyond.
5 Top Stock Trades for Wednesday: AAPL, MCD, SHOP
Apple will report after the close, while MCD, PFE, SHOP and NXPI have all reported earnings. They're our top stock trades.
Pfizer Stock Has Positive and Negative Catalysts Going Into Results
Pfizer stock has both negative and positive catalysts. The valuation of PFE stock is attractive, but investors shouldn;t rush to buy PFE.
Why Is Bristol-Myers Near 52-Week Lows?
Investors are punishing Bristol-Myers on the markets more than they should. BMY stock's acquisition of Celgene isn't the only reason.
Monday’s Vital Data: Pfizer, Canopy Growth Corp and Microsoft
Options trading was buzzing in Pfizer, Canopy Growth and Microsoft on Thursday. Here are the metrics that matter moving forward.
3 Big Stock Charts for Monday: Caterpillar, Lamb Weston and CF Industries
The stock charts of CAT, CF and LW stock are getting the new trading week going at major tipping points. Here's what you need to know.
Pfizer Stock Suffers From an Underappreciated Drugs Pipeline
PFE stock hasn't been a terribly rewarding name to own since the middle of last year, but Pfizer is doing everything it's supposed to do.
10 Dow Jones Stocks Holding the Blue Chip Index Back
Pfizer, Walgreens and Merck are just three of the Dow Jones stocks that have kept the index from doing as well as other market indices have this year.
3 Big Stock Charts for Wednesday: Twitter, Western Union and Wynn Resorts
The stock charts of TWTR, WYNN and WU make their way into the trading spotlight for this week's hump-day. Here's what to watch.
3 Big Stock Charts for Thursday: Pfizer, Coty and Pioneer Natural Resources
The stock charts of COTY, PFE and PXD are worth a closer technical inspection as we move into the latter half of the trading week.
The Case Against Pfizer Stock and the Rest of the Industry
A recent article in the investment media asked if Pfizer stock was a better buy than Eli Lilly stock. Here’s why I wouldn’t buy either.
The Roche Merger Will Do Wonders for Spark Stock
As Spark Therapeutics gets acquired, existing shareholders, and Roche investors, will need to eveluate the merits of the deal.
What Should Apple Do With Its Cash?
Apple's cash on hand figure of $245 billion gives the company a variety of options, but one possibility stands out among the rest.
